The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

Instead, a different type of medication called thiazide diuretics may work better and cause fewer side effects. Doctors have ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to taking Ozempic: It may help manage chronic kidney disease (CKD). On January ...

Questions remain about whether the renal effects of ACE inhibitors and ARBs are equivalent, whether a combination of the two classes are more effective than either one alone, and whether either ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

and kidney damage. The pharmacological treatments used most often to manage the blood pressure of obese patients include ACE inhibitors, ARBs, and diuretics. However, newer drugs such as GLP-1 ...

Chronic kidney disease is a common complication ... such as medicines to manage blood pressure, including ACE inhibitors and ARBs. About 3,500 adults across 28 countries were enrolled in the ...